Sight Sciences, Inc.

Sight Sciences, Inc.

SGHT·NASDAQ

$4.60

+6.0%
HealthcareMedical - Devices

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

At a Glance

Live Snapshot
Market Cap$250.29M
EPS-0.7400
P/E Ratio-6.22
Earnings Date08/06/2026

sght

Gross Profit

Last Annual Value

66.67M

3-Year CAGR

4%

5-Year CAGR

29%

10-Year CAGR

29%

Sight Sciences, Inc.

Sight Sciences, Inc. Competitors Analysis of Gross Profit

SGHT · NASDAQ
CompanyGross Profit
CAGR 3Y
CAGR 5Y
CAGR 10Y
66.67M
-1.2%10.6%N/A 
2.22B
1.5%8.0%6.5%
0.00
N/AN/AN/A
HYPR logo
Hyperfine, Inc.
NASDAQ:HYPR
6.75M
12.4%N/AN/A
MXCT logo
MaxCyte, Inc.
NASDAQ:MXCT
22.58M
-14.8%-5.7%7.5%
OWLT logo
Owlet, Inc.
NYSE:OWLT
53.50M
33.3%8.8%N/A
7.61M
N/AN/AN/A
38.19M
33.9%39.6%N/A
MASS logo
908 Devices Inc.
NASDAQ:MASS
28.42M
3.9%4.1%N/A
15.76M
72.1%N/AN/A
153.97M
10.9%16.0%23.4%
Sight Sciences, Inc.

Sight Sciences, Inc. Fair Value Envelope

SGHT · NASDAQ

Our analysis suggests that SGHT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.6, this represents a potential HIDDEN relative to our calculated worth for Sight Sciences, Inc..

Intrinsic Value
Current Price: $4.6